Pediatric

Migraine Study

Now Enrolling

Headache

Study Objective

Phase 3, Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Rimegepant for the Acute Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to <18 Years of Age.

Key Requirements:

  • >6 years old - <18 years old 

Study Information

  • Compensation for time and travel up to 

  • Transportation can be arranged at no cost to you 

  • Study related exams at to cost

Location:

  • TOPAZ Clinical Research 2513 E. Semoran Blvd Apopka, FL 32703

 

Thank you for your interest in this clinical trial. Please complete the short questionnaire below or feel free to contact us directly at 407-703-4342.
Do you have history of migraines?
Gender
arrow&amp;v

Your privacy is extremely important to us and this information is kept completely confidential. We take measures to protect the data  submitted on this website and we will never sell, trade or share your information with anyone.  

If you would rather speak directly to us do not hesitate to call 407-703-4342